Skip to content
10-Q

Quarterly Report

RXO, INC. RXO

0001929561-26-000026

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 164.92M sh
Shares Diluted Q1 2026 · Mar 31, 2026 169.1M sh
Shares Diluted Q1 2026 · Mar 31, 2025 168.02M sh
Capex Q1 2026 · Mar 31, 2026 $17M
Capex Q1 2026 · Mar 31, 2025 $15M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$7M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2M
Short Term Debt Q1 2026 · Mar 31, 2026 $17M
Short Term Debt Q1 2026 · Dec 31, 2025 $17M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $21M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $17M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.51B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.54B
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.59B
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.61B
Current Liabilities Q1 2026 · Mar 31, 2026 $1.05B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.04B
Current Assets Q1 2026 · Mar 31, 2026 $1.34B
Current Assets Q1 2026 · Dec 31, 2025 $1.32B
Total Assets Q1 2026 · Mar 31, 2026 $3.27B
Total Assets Q1 2026 · Dec 31, 2025 $3.28B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.21
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.18
Eps Basic Q1 2026 · Mar 31, 2026 −$0.21
Eps Basic Q1 2026 · Mar 31, 2025 −$0.18
Sga Expense Q1 2026 · Mar 31, 2026 $197M
Sga Expense Q1 2026 · Mar 31, 2025 $210M
Net Income Q1 2026 · Mar 31, 2026 −$36M
Net Income Q1 2026 · Mar 31, 2025 −$31M
Operating Income Q1 2026 · Mar 31, 2026 −$28M
Operating Income Q1 2026 · Mar 31, 2025 −$30M
Revenue Q1 2026 · Mar 31, 2026 $1.43B
Revenue Q1 2026 · Mar 31, 2025 $1.43B